CIC Holdings PLC Financial Summary and Investment Analysis

Executive Overview

CIC Holdings PLC is a leading diversified conglomerate in Sri Lanka with operations spanning Crop Solutions, Agri Produce, Livestock Solutions, Industrial Solutions, and Health & Personal Care. Despite a challenging macro-environment marked by currency depreciation and extreme weather events (such as Cyclone Ditwah), the company demonstrated robust resilience, recording a 10% consolidated revenue growth and a 25% profit growth for the 12 months ending Q1 2026. The growth was driven by strategic capacity expansions, aggressive export market penetration, and a shift towards value-added, climate-resilient products.

• Key periods covered: Q3 2024 to Q2 2026 (Calendar Years).

Financial Performance

Revenue and Profitability Trends

The company has shown consistent top-line growth and margin preservation across recent quarters. The Crop Solutions and Livestock Solutions segments remain the largest revenue contributors, while Health & Personal Care showed exceptional profitability growth driven by exports.

Analysis:

• YoY Growth: Revenue for the 12 months ending Q1 2026 grew by 10.16% YoY, while Net Profit surged by 24.5%. Q2 2026 maintained this momentum with a 2.74% YoY revenue increase and a 19.69% YoY net profit increase compared to Q2 2025.
• Margin Stability: Despite rising input costs, global fertilizer price hikes, and local currency depreciation, GP margins stabilized around 26-27%. This was achieved through strategic pricing, product mix optimization, and cost-control measures.
• Segmental Highlights: Crop Solutions generated 41% of Group revenue, growing 12% YoY. Health & Personal Care saw a massive 34% bottom-line growth, heavily supported by a 62% surge in export sales of flagship brands like Samahan.

Balance Sheet Analysis

The company maintains a strong and expanding asset base, heavily supported by retained earnings and strategic investments in property, plant, equipment, and equity associates.

Analysis:

• Liquidity: The current ratio stands at approximately 1.21x (Q2 2026), indicating adequate short-term liquidity. However, current liabilities are heavily weighted by short-term bank borrowings (Rs. 26.91 Bn in Q2 2026), requiring proactive working capital management.
• Solvency: The Debt/Equity ratio improved to 56.08% by Q1 2026, down from 60.82% in the prior year. Total debt remains manageable, heavily skewed toward short-term financing for operational needs.
• Asset Growth: Total assets grew by 12% in the 12 months leading to Q1 2026, driven by an increase in equity-accounted investees (notably John Keells Holdings PLC) and capital expenditure in manufacturing infrastructure.

Cash Flow Analysis

Analysis:

• Operating Cash Flow: Showed robust improvement, generating Rs. 5.45 Bn in the 12M to Q1 2026, up from Rs. 3.69 Bn the previous year, reflecting strong cash conversion and inventory management despite macro stresses.
• Investing Activities: Heavy outflows were driven by a strategic investment in an associate company (John Keells Holdings PLC) and Rs. 2 Bn in capital expenditure for infrastructure upgrades (e.g., Maho rice mill, feed mill expansions).
• Free Cash Flow: Operational cash generation comfortably covers dividend payouts and routine CAPEX, though strategic acquisitions required some debt utilization.

Key Financial Ratios and Growth Indicators

*\*Adjusted for 1:5 share sub-division executed in October 2025.*

Other Indicators:

• R&D Investments: Rs. 474.1 Mn invested in R&D during the 12M ending Q1 2026, resulting in the launch of 49 new products (e.g., Vibelsol coated urea, Nico maize herbicide, Jelly Collagen, WoundClot surgical gauze).
• Export Growth: Herbal & Personal care exports expanded by 54%, establishing new footholds in African and Australian markets.

Economic and Market Context

• Macro Recovery: The Sri Lankan economy registered a 5% GDP growth in 2025, rebounding from prior contractions. Inflation stabilized to single digits (2.9% by Dec 2025).
• Currency & Global Factors: The Sri Lankan Rupee depreciated by 5.6% against the USD in 2025, escalating import costs for raw materials. Global supply chains remained volatile due to Middle East tensions, elevating freight and fertilizer prices.
• Climate Impact: Cyclone Ditwah in November 2025 severely impacted local agriculture, disrupting Q4 2025 and Q1 2026 demand cycles, and causing significant losses in dairy cattle, which spiked raw milk prices and pressured dairy margins.

Future Potential and Outlook

• Capacity Expansions: The company is executing aggressive CAPEX. This includes a 30% capacity increase in feed milling (expected FY2026/27), a second rice processing line in Maho, the acquisition of a 35-acre poultry farm, and a 5MW rooftop solar installation to mitigate energy costs.
• Value Addition & Exports: A strategic pivot away from basic commodities to high-margin, value-added products (e.g., dehydrated fruits, specialized low-GI rice, and targeted Green Chemistry Class III/IV crop solutions).
• Digitalization: Rollout of SAP RISE, Sales Force Automation (SFA), and a centralized HRIS are expected to drive significant operational efficiencies and data-driven decision-making.

Risks and Challenges

• Climate Vulnerability: High exposure to erratic weather (droughts, cyclones) directly impacts the Agri Produce and Crop Solutions segments. *Mitigation:* Investments in climate-resilient seed varieties, smart agriculture tech, and enhanced buffer stocking.
• Regulatory & Transition Risks: Government push towards organic farming and bans on high-toxicity agrochemicals risk product obsolescence. *Mitigation:* Development of in-house organo-mineral fertilizers and partnerships for low-impact chemical alternatives.
• Forex and Supply Chain: High dependency on imported raw materials (pharmaceuticals, packaging, industrial chemicals). *Mitigation:* Aggressive export portfolio expansion to create natural FX hedges, and supply chain diversification.

Shareholder and Corporate Information

• Major Shareholders: Paints & General Industries Limited is the controlling shareholder (53.31%), followed by the Employee's Provident Fund (9.06%).
• Corporate Action: A 1:5 share sub-division was executed on October 13, 2025, increasing liquidity and adjusting the outstanding ordinary shares to 1,458,000,000.
• Public Holding: Float remains healthy at 46.69% for ordinary shares.
• Dividend: A final dividend of Rs. 0.50 per share was proposed for the period ending Q1 2026.
• Valuation: Post-split, the stock traded around Rs. 29.90 (Q1 2026), presenting a highly compressed P/E ratio of 8.21x compared to the previous year, suggesting value unlocking post-recovery.

Investment Decision Indicators

Strengths:

• Market leadership across vital domestic sectors (Agri, Pharmaceuticals, Livestock).
• Resilient margin profile (26% GP margin) despite severe macro and climatic headwinds.
• Highly diversified revenue streams mitigate sector-specific downturns.
• Strong cash generation and improving return metrics (ROE 15%, ROCE 18%).
• Strategic equity stake (approx. 23.92% voting rights via proxies/holdings) in John Keells Holdings PLC bolsters the balance sheet.

Weaknesses:

• Heavy reliance on short-term borrowings for working capital exposes the company to interest rate volatility.
• Significant exposure to unpredictable government policy shifts (price caps on pharmaceuticals, agrochemical bans).
• Dairy segment margins remain highly sensitive to local raw milk supply shocks.

Opportunities:

• Rapidly growing export footprint, specifically in Ayurvedic/herbal products and specialty rice.
• Rising domestic health consciousness driving demand for wellness products and safe agri-inputs.
• Internal cost optimization through renewable energy integration (solar) and digital transformation.

Threats:

• Escalation of geopolitical tensions disrupting global supply chains and raising import costs.
• Accelerated climate change increasing the frequency of yield-destroying weather events.
• Sustained LKR depreciation squeezing margins on imported pharmaceutical and industrial inputs.

Overall Assessment Rationale:

• For a BUY: The stock demonstrates deep intrinsic value with a low P/E ratio (8.21x), strong asset backing (NAV Rs. 24.37), and an improving macroeconomic environment. The successful navigation of extreme weather and currency depreciation, combined with proactive capacity expansions and export growth, signals strong future earnings potential.
• For a HOLD: Existing investors might prefer to hold to capture the yields from recent CAPEX (new feed mills, rice lines) and digitalization efficiencies. The 1:5 stock split has improved liquidity, making it easier to hold while waiting for export revenues to mature.
• For a SELL: Investors highly averse to climate-related agricultural risks, regulatory interventions in the pharmaceutical/agri spaces, or concerned by the high proportion of short-term debt in a volatile interest rate environment might consider exiting.